Xealth is a digital health prescribing platform that enables clinicians to easily integrate, prescribe and monitor digital health tools for patients from their EHR workflows.
Xealth enables healthcare teams to order digital content and services as easily as they do orders and medications today. Patients can then access these digital health prescriptions from the provider's portal, so that they can actively manage their health.
Xealth was founded in 2017 by Mike McSherry, Eric Fu, Sundar Balasubramanian, & Aaron Sheedy and is based Seattle, Washington.
Xealth uses a patient data to recommend services from a variety of vendors for possible prescription.
Xealth offers Xealth platform, that allows clinicians to find and order the right digital tools and programs for patients direct from the EHR workflow, send these digital health orders to the patient’s smartphone or desktop, and then monitor patient engagement and analyze the effects of more engaged patients.
Xealth empowers patients to help manage their health by giving them readily available digital tools and important information, which are directly connected to their care team and health system.
Xealth can integrate a dozen digital health vendors in the same time it takes to integrate just one. This allows IT and IS teams to focus on running the health system, while Xealth manages the digital care.
Xealth is backed by investors including McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC, Atrium Health, MemorialCare, and the Froedtert and Medical College of Wisconsin Health Network. The company raised $3M in it's latest "Series A" funding on Jun 20, 2019. This brings Xealth's total funding to $22.5M.